Results 131 to 140 of about 1,385 (194)

A patient-derived CABIN1 mutation recapitulates features of idiopathic multicentric Castleman disease in a mouse model. [PDF]

Blood Adv
Laczko D, Tsao P, Pai RA, Zinski J, Gonzalez MV, Mumau MD, Raabe T, Muramatsu H, Pardi N, Kambayashi T, Fajgenbaum DC.   +10 more
europepmc   +1 more source

Impact of siltuximab on patient-related outcomes in multicentric Castleman’s disease [PDF]

core   +2 more sources

Castleman Disease in a Child: A Rare Cause of Persistent Cervical Lymphadenopathy. [PDF]

Cureus
Dutta A, Sarma D, Medhi P, Banik A, Rabha SK.   +4 more
europepmc   +1 more source

Castleman disease. [PDF]

Reumatologia
Qasim J, Ramasamy K.
europepmc   +1 more source

The aggravating fury rituximab obliterated [PDF]

Ammar Al-Obaidi, Furha Cossor, Himil Mahadevia   +2 more
core   +2 more sources

Oligocentric Castleman Disease (OligoCD): A Novel Diagnostic Entity in the Spectrum of Castleman Disease. [PDF]

Cureus
Baisya R, Nehil J, Dagar V, Manna S.
europepmc   +1 more source

The rare report of unicentric Castleman disease with concurrent myasthenia gravis and paraneoplastic pemphigus: a case report with a focused review of the literature. [PDF]

Front Oncol
Cheng Z, Liu W, Hu Y.
europepmc   +1 more source

TAFRO syndrome: current perspectives [PDF]

core   +2 more sources

Castleman Disease-Still More Questions than Answers: A Case Report and Review of the Literature. [PDF]

J Clin Med
Sikora M, Dąbrowska-Leonik N, Buda P, Wolska-Kuśnierz B, Jahnz-Różyk K, Pac M, Więsik-Szewczyk E.   +6 more
europepmc   +1 more source

Unicentric Castleman disease treated with rituximab before surgery: clinicopathologic findings. [PDF]

Ann Hematol
Paulli M, Neri G, Antoci F, D'Este E, Minetto M, Carpi F, Fauci M, Gambacorta M, Lucioni M, Arcaini L.   +9 more
europepmc   +1 more source